Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Subclade K (previously known as J.2.4.1) is gaining attention because it appears to be spreading much earlier in the flu ...
As Lindsey Vonn’s comeback run heads toward a peak with Team USA at the upcoming 2026 Winter Olympics, Invivyd is adding the ...
Ellipses Pharma Limited (“Ellipses”), a clinical-stage oncology drug development company with a pipeline of innovative ...
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...
LeAnn Rimes undergoes $10,000 plasma exchange treatment to remove "micro-toxins" from her body. The country star shares her ...
LeAnn Rimes is starting 2026 by putting her body front and center after what she described as an exhausting stretch ...
Data suggest that remote patient monitoring may support outpatient step-up dosing of bispecific antibodies by enabling earlier CRS detection.
A new blood test may reveal Crohn’s disease years before symptoms begin. The test detects an unusual immune response to gut bacteria in people who later develop the condition. By studying healthy ...
Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...
NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most sign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback